InvestorsHub Logo
Followers 48
Posts 9785
Boards Moderated 1
Alias Born 01/31/2008

Re: McMagyar post# 298771

Saturday, 02/13/2021 1:31:27 PM

Saturday, February 13, 2021 1:31:27 PM

Post# of 465854
ONE EXISTS: Zero as in none..
Dr M will not trust this drug to any other leader..


what i DO think will happen IS..Adjunctive Therapy Partnerships..
and can anyone GUESS who the first candidate will be?


THE ONE: Anatabine citrate. Medically proven to help against alzheimers!

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444019/

Anavex can 100% control an adjunctive therapy trial with anatabine citrate.

Therefore it fits the scientific criteria of reducing alz holistically like 273 and allows 100% AVXL control as it is readily available.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News